Abstract: Diabetes mellitus (DM) is a serious chronic metabolic disease which disease afflicting at present now afflicts approximately 4% of world population worldwide. Patients with metabolic syndrome suffer from both dyslipidemia and diabetes mellitus. Diabetic, male KKAy mice, aged 14 weeks were randomly divided into a model group and an astragalus treatment group, while age-matched male C57BL/6J mice were selected as controls. We hypothesized that the expression of PTP1B may be regulated by ATF6 when ER stress happened. It also has antioxidant effects, protecting cells against damage by free radicals, as well as adaptogenic effects, meaning it helps the body respond and adapt more positively to environmental stress factors, both physiological and psychological. Two assessors independently reviewed each trial. There was no difference in hemodynamic parameters between two groups.
Moreover, astragalus stimulates natural killer cells whose job is to keep the infection from spreading. Results: Compared with diabetic rats, oral administration of AMBE at a concentration of 160 mg/kg daily for 30 days showed a significant decrease in fasting blood glucose (109.438 ± 3.52, p < 0.05) and increased insulin level (13.96 ± 0.74, p < 0.05). Astragalus has also shown that it can slow telomere shortening, giving us further clues as to how to promotes longevity. These effects of AC may facilitate the treatment of type 1 or 2 diabetes, as these patients frequently experience impaired islet function and disordered extrapancreatic metabolism. The TianZi Biodiversity Centre is working with German Universities to design land use systems, which are bound to change paradigms: we promote rare agro-biodiversity species, manage complexity, and find alternatives to destructive forms of mono culture. These are strokesthat are caused by a rupture in a weakened blood vessel in the brain. Therefore, the purpose of many diabetic drugs is to lower blood sugar levels and improve insulin sensitivity. However, it does interact with a number of other herbs and prescription medications. Due to these anti-diabetic effects, astragalus may show promise as a potential treatment for Type 2 diabetes. Some studies have shown that when individuals suffering from seasonal allergies took this herb for atleast 6 months, there were reduced instances of cold symptoms such as – runny nose, sneezing and itching. In a study published in the July 2012 issue of “BMC Complementary and Alternative Medicine,” drug-resistant cancer cells were exposed to the combination of astragalus polysaccharides and chemotherapy drugs. The study found that by adding astragalus polysaccharides to the drugs, the cancer cells that were previously resistant to chemotherapy drugs became sensitive. 92 patients with Ischemic heart disease treated with Astragalus, had a significant relief from angina (chest pain) and also an improvement in the effective rate of EKG (Electrocardiogram) by 82.6%.